The role of the transition metal copper and the ionophore A23187 in the development of irinophore C™

Pharmaceutical Research

Volumn 28, Issue 4, 2011, Pages 848-857

  Patankar, Nilesh ^a,b   Anantha, Malathi ^b   Ramsay, Euan ^b,c   Waterhouse, Dawn ^a,b   Bally, Marcel ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c Centre for Drug Research and Development   (Canada)

Author keywords

copper; ionophore; irinotecan; liposomes

Indexed keywords

CALCIMYCIN; COPPER; IRINOPHORE C; IRINOTECAN; LIPOSOME; MANGANESE; TOPOTECAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG RELEASE; DRUG RETENTION; ENCAPSULATION; FEMALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIMYCIN; CAMPTOTHECIN; CELL MEMBRANE PERMEABILITY; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPPER; FEMALE; IONOPHORES; LIPOSOMES; MICE; MICE, INBRED BALB C; PHOSPHATIDYLCHOLINES;

EID: 79955610767     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0340-2     Document Type: Article

References (34)

1. AN Gordon JT Fleagle D Guthrie DE Parkin ME Gore AJ Lacave 2001 Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan J Clin Oncol. 19 3312 3322 11454878 1:CAS:528:DC%2BD3MXlvVamsr8%3D (Pubitemid 32642183)
2. G Batist G Ramakrishnan CS Rao A Chandrasekharan J Gutheil T Guthrie P Shah A Khojasteh MK Nair K Hoelzer K Tkaczuk YC Park LW Lee 2001 Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer J Clin Oncol. 19 1444 1454 11230490 1:CAS:528:DC%2BD3MXit1ertLg%3D (Pubitemid 32202552)
3. A Dicko P Tardi X Xie L Mayer 2007 Role of copper gluconate/ triethanolamine in irinotecan encapsulation inside the liposomes Int J Pharm. 337 219 228 17270372 10.1016/j.ijpharm.2007.01.004 1:CAS:528: DC%2BD2sXlsFagsrk%3D (Pubitemid 46756052)
4. DL Emerson 2000 Liposomal delivery of camptothecins Pharm Sci Technolo Today. 3 205 209 10840391 10.1016/S1461-5347(00)00268-6 1:CAS:528: DC%2BD3cXjvFKnur4%3D (Pubitemid 30364934)
5. G Haran R Cohen LK Bar Y Barenholz 1993 Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim Biophys Acta. 1151 201 215 8373796 10.1016/0005-2736(93) 90105-9 1:CAS:528:DyaK2cXjsl2huw%3D%3D (Pubitemid 23283973)
6. CL Messerer EC Ramsay D Waterhouse R Ng EM Simms N Harasym P Tardi LD Mayer MB Bally 2004 Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer Clin Cancer Res. 10 6638 6649 15475454 10.1158/1078-0432.CCR-04-0221 1:CAS:528:DC%2BD2cXot1Oiu7g%3D (Pubitemid 39346561)
7. E Ramsay J Alnajim M Anantha A Taggar A Thomas K Edwards G Karlsson M Webb M Bally 2006 Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation Pharm Res. 23 2799 2808 17063397 10.1007/s11095-006-9111-5 1:CAS:528:DC%2BD28Xht1Kmt7%2FF (Pubitemid 44885367)
8. EC Ramsay M Anantha J Zastre M Meijs J Zonderhuis D Strutt MS Webb D Waterhouse MB Bally 2008 Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors Clin Cancer Res. 14 1208 1217 18281556 10.1158/1078-0432.CCR-07-0780 1:CAS:528:DC%2BD1cXhvF2ntrw%3D (Pubitemid 351302570)
9. Burke TG, Xiang Xiang T, Anderson B, Latus L. Recent advances in camptothecin drug design and delivery strategies. Totowa: Humana Press Inc.
10. PG Tardi RC Gallagher S Johnstone N Harasym M Webb MB Bally LD Mayer 2007 Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo Biochim Biophys Acta. 1768 678 687 17208196 10.1016/j.bbamem.2006.11.014 1:CAS:528:DC%2BD2sXit1Kjtrk%3D (Pubitemid 46275599)
11. E Ramsay J Alnajim M Anantha J Zastre H Yan M Webb D Waterhouse M Bally 2008 A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention Eur J Pharm Biopharm. 68 607 617 17904831 10.1016/j.ejpb.2007.08.011 1:CAS:528:DC%2BD1cXjtVeksbg%3D (Pubitemid 351318211)
12. JH Baker J Lam AH Kyle J Sy T Oliver SJ Co WH Dragowska E Ramsay M Anantha TJ Ruth MJ Adam A Yung P Kozlowski AI Minchinton SS Ng MB Bally DT Yapp 2008 Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin Clin Cancer Res. 14 7260 7271 19010842 10.1158/1078-0432.CCR-08-0736 1:CAS:528:DC%2BD1cXhtlylur7P
13. BC Cheung TH Sun JM Leenhouts PR Cullis 1998 Loading of doxorubicin into liposomes by forming Mn2+-drug complexes Biochim Biophys Acta. 1414 205 216 9804955 10.1016/S0005-2736(98)00168-0 1:CAS:528:DyaK1cXntVyju7s%3D (Pubitemid 28511051)
14. SA Abraham K Edwards G Karlsson N Hudon LD Mayer MB Bally 2004 An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes J Control Release. 96 449 461 15120901 10.1016/j.jconrel.2004. 02.017 1:CAS:528:DC%2BD2cXjsFOltL0%3D (Pubitemid 38553923)
15. N Dos Santos D Waterhouse D Masin PG Tardi G Karlsson K Edwards MB Bally 2005 Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity J Control Release. 105 89 105 15878792 10.1016/j.jconrel.2005.03.007 (Pubitemid 40805478)
16. T Kamidate Y Hashimoto H Tani A Ishida 2002 Uptake of transition metal ions using liposomes containing dicetylphosphate as a ligand Anal Sci. 18 273 276 11918184 10.2116/analsci.18.273 1:CAS:528:DC%2BD38XitFCmtrk%3D
17. AS Taggar J Alnajim M Anantha A Thomas M Webb E Ramsay MB Bally 2006 Copper-topotecan complexation mediates drug accumulation into liposomes J Control Release. 114 78 88 16842880 10.1016/j.jconrel.2006.05.019 1:CAS:528:DC%2BD28XnsFCrtrY%3D (Pubitemid 44128628)
18. PR Cullis MJ Hope MB Bally TD Madden LD Mayer DB Fenske 1997 Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles Biochim Biophys Acta. 1331 187 211 9325441 1:CAS:528:DyaK2sXlt1Gntb0%3D (Pubitemid 27387443)
19. MJ Burkitt 2001 A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin Arch Biochem Biophys. 394 117 135 11566034 10.1006/abbi.2001.2509 1:CAS:528:DC%2BD3MXmvFSltLg%3D (Pubitemid 32948291)
20. CD Davis 2003 Low dietary copper increases fecal free radical production, fecal water alkaline phosphatase activity and cytotoxicity in healthy men J Nutr. 133 522 527 12566494 1:CAS:528:DC%2BD3sXhtV2nurk%3D (Pubitemid 36172910)
21. D Strausak JF Mercer HH Dieter W Stremmel G Multhaup 2001 Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases Brain Res Bull. 55 175 185 11470313 10.1016/S0361-9230(01)00454-3 1:CAS:528:DC%2BD3MXltlOitLg%3D (Pubitemid 32722157)
22. M Valko H Morris MT Cronin 2005 Metals, toxicity and oxidative stress Curr Med Chem. 12 1161 1208 15892631 10.2174/0929867053764635 1:CAS:528:DC%2BD2MXktlant7g%3D (Pubitemid 40655271)
23. LD Mayer MJ Hope PR Cullis 1986 Vesicles of variable sizes produced by a rapid extrusion procedure Biochim Biophys Acta. 858 161 168 3707960 10.1016/0005-2736(86)90302-0 1:STN:280:DyaL283hs1WqsA%3D%3D
24. H Franke HJ Galla CT Beuckmann 1999 An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol Brain Res. 818 65 71 9914438 10.1016/S0006-8993(98)01282-7 1:CAS:528:DyaK1MXmtVCrtg%3D%3D (Pubitemid 29227284)
25. PP Van Veldhoven WW Just GP Mannaerts 1987 Permeability of the peroxisomal membrane to cofactors of beta-oxidation. Evidence for the presence of a pore-forming protein J Biol Chem. 262 4310 4318 3031070
26. J Kuwahara T Suzuki K Funakoshi Y Sugiura 1986 Photosensitive DNA cleavage and phage inactivation by copper(II)-camptothecin Biochemistry. 25 1216 1221 3008823 10.1021/bi00354a004 1:CAS:528:DyaL28Xht1Grsrk%3D (Pubitemid 16048092)
27. VS Lebedev LA Volodina E Deinega I Fedorov Iu 2005 Structural modifications of the surface of Escherichia coli bacteria and copper-induced permeability of plasma membrane Biofizika. 50 107 113 15759509 1:CAS:528:DC%2BD2MXhs1Ogt78%3D
28. GB Khomutov SA Yakovenko ES Soldatov VV Khanin MD Nedelcheva TV Yurova 1997 Interaction of copper ions with stearic acid Langmuir monolayers and formation of cluster structures in monolayers and Langmuir-Blodgett films Membr Cell Biol. 10 665 681 9231365 1:STN:280:DyaK2sznsV2qsg%3D%3D (Pubitemid 27196684)
29. M Suwalsky B Ungerer L Quevedo F Aguilar CP Sotomayor 1998 Cu2+ ions interact with cell membranes J Inorg Biochem. 70 233 238 9720309 10.1016/S0162-0134(98)10021-1 1:CAS:528:DyaK1cXlsVWjtLs%3D (Pubitemid 28384915)
30. B Elorza MA Elorza MC Sainz JR Chantres 1993 Analysis of the particle size distribution and internal volume of liposomal preparations J Pharm Sci. 82 1160 1163 8289133 10.1002/jps.2600821119 1:CAS:528:DyaK2cXhsVyisw%3D%3D (Pubitemid 24004451)
31. N Maurer KF Wong MJ Hope PR Cullis 1998 Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study Biochim Biophys Acta. 1374 9 20 9814848 10.1016/S0005-2736(98)00125-4 1:CAS:528:DyaK1cXlvFentbk%3D (Pubitemid 28432041)
32. Kuwahara J, Suzuki T, Sugiura Y. Studies on antitumor drugs targeting DNA: photosensitive DNA cleavage of copper-camptothecin. Nucleic Acids Symp Ser 1985;201-204
33. EP Bruggemannand DL Melchior 1983 Alterations in the organization of phosphatidylcholine/cholesterol bilayers by tetrahydrocannabinol J Biol Chem 258 8298 8303 (Pubitemid 13074111)
34. JC Kim SK Bae JD Kim 1997 Temperature-sensitivity of liposomal lipid bilayers mixed with poly(N-isopropylacrylamide-co-acrylic acid) J Biochem. 121 15 19 9058185 1:CAS:528:DyaK2sXhslKrsbk%3D (Pubitemid 27068268)